DENVER--(BUSINESS WIRE)--Ceragenix Pharmaceuticals, Inc. (OTCBB:CGXP), a biopharmaceutical company focused on infectious disease and dermatology, today announced that it will conduct a live webcast to present data on the use of Ceragenins to prevent bacterial colonization of medical devices as well as its ability to virtually eradicate bacteria and fungi as a contact lens disinfectant.
